MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/joneph/aajag121

Медицинская библиотека · Journal of nephrology · 2026

Anti-PLA2R antibody levels are associated with thromboembolism risk in individuals with membranous nephropathy and hypoalbuminemia.

Al Jurdi Ayman, El Mouhayyar Christopher, Yatim Karim, Efe Orhan, Muhsin Saif A, Riella Leonardo V, Zonozi Reza, Laliberte Karen, Niles John L, Jeyabalan Anushya

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Studies to evaluate markers of thrombotic risk in individuals with high-risk membranous nephropathy (MN) are needed. We hypothesized that high anti-phospholipase A2 receptor (PLA2R) titers at the time of severe hypoalbuminemia, reflecting ongoing immunologic disease activity, may be associated with a higher risk of thrombotic complications.

METHODS

We conducted a multicenter retrospective cohort study of individuals with membranous nephropathy and serum albumin <2.5 g/dL and evaluated risk factors for first thrombotic events.

RESULTS

Sixty-seven individuals met the inclusion criteria. Median serum creatinine was 1.2 mg/dL (Interquartile range [IQR] 0.9-1.6), median urine protein-to-creatinine ratio (UPCR) was 11.9 g/g (IQR 8.5-16.5), and median nadir serum albumin level was 1.9 g/dL (IQR 1.6-2.2). Twenty-four individuals (36%) received no thromboprophylaxis, 20 (30%) received prophylaxis with only antiplatelets, and 23 (34%) received anticoagulation prophylaxis. Thrombotic events occurred in 11 individuals (16%) with incidence rates of 0.11, 0.10, and 0.02 per person-year in the no prophylaxis, antiplatelet, and anticoagulation groups, respectively. In individuals with anti-PLA2R antibody-positive MN who did not receive anticoagulation thromboprophylaxis, higher anti-PLA2R antibody levels were associated with a higher risk of developing thrombotic complications (adjusted Hazard Ratio [HR] = 1.51 per 10 RU/mL increase in PLA2R, 95% Confidence Interval [CI]: 1.10-2.09, P = .012) after adjusting for serum albumin nadir and age.

CONCLUSIONS

Higher anti-PLA2R antibody levels at the time of hypoalbuminemia are associated with a higher risk of thrombotic complications in individuals with anti-PLA2R-positive MN.

Для цитирования: Al Jurdi Ayman, El Mouhayyar Christopher, Yatim Karim, Efe Orhan, Muhsin Saif A, Riella Leonardo V, Zonozi Reza, Laliberte Karen, Niles John L, Jeyabalan Anushya. Anti-PLA2R antibody levels are associated with thromboembolism risk in individuals with membranous nephropathy and hypoalbuminemia.. Journal of nephrology. 2026. DOI: 10.1093/joneph/aajag121.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.